OSI Systems Reports Third Quarter Fiscal 2019 Financial Results
- Record Revenue of
$304 Million (14% increase over prior year) - Record Q3 Earnings Per Diluted Share
- GAAP EPS of
$1.05 - Non-GAAP EPS of
$1.17 (36% increase over prior year)
- GAAP EPS of
- Company Raises Fiscal Year 2019 Guidance
The Company reported revenues of
For the nine months ended
The Company's backlog was
Mr. Chopra commented, “Our Security division delivered record third quarter revenues of
“As we noted last quarter, we are building positive momentum in the Healthcare division. Led by the performance in
Mr. Chopra concluded, “Our Optoelectronics and Manufacturing division continued to perform well, delivering 7% year-over-year sales growth and a strong operating margin.”
The Company’s effective tax rate for the three and nine months ended
Fiscal Year 2019 Outlook
The Company is raising its fiscal 2019 sales guidance from the previous range of
The Company’s fiscal 2019 diluted earnings per share guidance is provided on a non-GAAP basis only. The Company does not provide a reconciliation of guidance for non-GAAP diluted EPS to GAAP diluted EPS (the most directly comparable GAAP measure) on a forward-looking basis because the Company is unable to provide a meaningful or accurate compilation of reconciling items and certain information is not available. This is due to the inherent difficulty and complexity in accurately forecasting the timing and amounts of various items that would be excluded from GAAP diluted EPS, including, for example, acquisition costs and other non-recurring items that have not yet occurred, are out of the Company’s control, or cannot be reasonably predicted. For the same reasons, the Company is unable to address the probable significance of unavailable information which may be material and therefore could result in GAAP diluted EPS, the corresponding GAAP financial measure, being materially less than projected non-GAAP diluted EPS.
Presentation of Non-GAAP Financial Measures
This earnings release includes a presentation of non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP operating income (loss) by segment and non-GAAP operating margin, all of which are non-GAAP financial measures. The presentation of these non-GAAP figures for the three and nine month periods ended
Reconciliations of GAAP to non-GAAP financial information are provided in the accompanying tables. The financial results calculated in accordance with GAAP and reconciliations from those financial results should be carefully evaluated.
Conference Call Information
The Company will host a conference call and simultaneous webcast beginning at
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company's current expectations, beliefs, and projections concerning matters that are not historical facts.Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside the Company's control and which may cause actual results to differ materially from those described in or implied by any forward-looking statement. Forward-looking statements include, but are not limited to, information provided regarding expected revenues, earnings, growth, and operational performance in fiscal 2019. The Company could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; unanticipated impacts of sequestration and other
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (in thousands, except per share data) |
||||||||||||||||
Three Months Ended
March 31, |
Nine Months Ended
March 31, |
|||||||||||||||
2018 | 2019 | 2018 | 2019 | |||||||||||||
Revenues | $ | 267,299 | $ | 304,284 | $ | 801,960 | $ | 873,738 | ||||||||
Cost of goods sold | 169,714 | 192,968 | 511,474 | 556,165 | ||||||||||||
Gross profit | 97,585 | 111,316 | 290,486 | 317,573 | ||||||||||||
Operating expenses: | ||||||||||||||||
Selling, general and administrative | 59,846 | 67,278 | 175,591 | 196,082 | ||||||||||||
Research and development | 15,934 | 13,695 | 46,122 | 40,253 | ||||||||||||
Impairment, restructuring and other charges | 14,062 | (1,777 | ) | 23,489 | 1,154 | |||||||||||
Total operating expenses | 89,842 | 79,196 | 245,202 | 237,489 | ||||||||||||
Income from operations | 7,743 | 32,120 | 45,284 | 80,084 | ||||||||||||
Interest expense, net | (4,783 | ) | (5,603 | ) | (14,317 | ) | (16,546 | ) | ||||||||
Other income, net | 158 | 8 | 161 | - | ||||||||||||
Income before income taxes | 3,118 | 26,525 | 31,128 | 63,538 | ||||||||||||
Provision for income taxes | (565 | ) | (6,899 | ) | (65,369 | ) | (15,403 | ) | ||||||||
Net income (loss) | $ | 2,553 | $ | 19,626 | $ | (34,241 | ) | $ | 48,135 | |||||||
Diluted earnings (loss) per share | $ | 0.13 | $ | 1.05 | $ | (1.82 | ) | $ | 2.58 | |||||||
Weighted average shares outstanding – diluted | 19,146 | 18,671 | 18,773 | 18,678 | ||||||||||||
SEGMENT INFORMATION (UNAUDITED) (in thousands) |
||||||||||||||||
Three Months Ended |
Nine Months Ended
March 31, |
|||||||||||||||
2018 | 2019 | 2018 | 2019 | |||||||||||||
Revenues – by Segment: | ||||||||||||||||
Security division | $ | 170,270 | $ | 193,486 | $ | 504,784 | $ | 552,130 | ||||||||
Healthcare division | 43,758 | 48,865 | 141,793 | 138,697 | ||||||||||||
Optoelectronics and Manufacturing division (including intersegment revenues) | 66,212 | 70,927 | 189,024 | 213,900 | ||||||||||||
Intersegment eliminations | (12,941 | ) | (8,994 | ) | (33,641 | ) | (30,989 | ) | ||||||||
Total | $ | 267,299 | $ | 304,284 | $ | 801,960 | $ | 873,738 | ||||||||
Operating income (loss) – by Segment: | ||||||||||||||||
Security division | $ | 21,028 | $ | 24,943 | $ | 66,192 | $ | 74,056 | ||||||||
Healthcare division | (8,425 | ) | 5,418 | (6,975 | ) | 5,752 | ||||||||||
Optoelectronics and Manufacturing division | 6,547 | 7,320 | 16,224 | 22,212 | ||||||||||||
Corporate | (10,730 | ) | (5,354 | ) | (28,601 | ) | (21,265 | ) | ||||||||
Intersegment eliminations | (677 | ) | (207 | ) | (1,556 | ) | (671 | ) | ||||||||
Total | $ | 7,743 | $ | 32,120 | $ | 45,284 | $ | 80,084 | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) |
||||||
(in thousands) | ||||||
June 30, 2018 | March 31, 2019 | |||||
Assets | ||||||
Cash and cash equivalents | $ | 84,814 | $ | 107,649 | ||
Accounts receivable, net | 210,744 | 218,433 | ||||
Inventories | 313,552 | 297,704 | ||||
Other current assets | 41,587 | 35,050 | ||||
Total current assets | 650,697 | 658,836 | ||||
Property and equipment, net | 115,524 | 124,916 | ||||
Goodwill | 292,213 | 307,461 | ||||
Intangible assets, net | 142,001 | 136,432 | ||||
Other non-current assets | 55,256 | 56,470 | ||||
Total Assets | $ | 1,255,691 | $ | 1,284,115 | ||
Liabilities and Stockholders' Equity | ||||||
Bank lines of credit | $ | 113,000 | $ | 124,000 | ||
Current portion of long-term debt | 2,262 | 1,702 | ||||
Accounts payable and accrued expenses | 194,815 | 168,853 | ||||
Other current liabilities | 133,245 | 130,945 | ||||
Total current liabilities | 443,322 | 425,500 | ||||
Long-term debt | 248,980 | 255,411 | ||||
Other long-term liabilities | 73,953 | 77,396 | ||||
Total liabilities | 766,255 | 758,307 | ||||
Total stockholders’ equity | 489,436 | 525,808 | ||||
Total Liabilities and Stockholders’ Equity | $ | 1,255,691 | $ | 1,284,115 | ||
RECONCILIATION OF GAAP TO NON-GAAP NET INCOME (LOSS) AND EARNINGS (LOSS) PER SHARE (in thousands, except share and earnings per share data) |
||||||||||||||||||||||||||||||||
Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||
2018 | 2019 | 2018 | 2019 | |||||||||||||||||||||||||||||
Net |
EPS |
Net |
EPS |
Net |
EPS |
Net |
EPS | |||||||||||||||||||||||||
GAAP basis | $ | 2,553 | $ | 0.13 | $ | 19,626 | $ | 1.05 | $ | (34,241 | ) | $ | (1.82 | ) | $ | 48,135 | $ | 2.58 | ||||||||||||||
Impairment, restructuring and other charges | 14,062 | 0.73 | (1,777 | ) | (0.10 | ) | 23,489 | 1.25 | 1,154 | 0.06 | ||||||||||||||||||||||
Amortization of acquired intangible assets | 3,994 | 0.21 | 3,822 | 0.21 | 11,070 | 0.59 | 12,012 | 0.65 | ||||||||||||||||||||||||
Non-cash interest | 1,884 | 0.10 | 1,970 | 0.11 | 5,558 | 0.30 | 5,851 | 0.31 | ||||||||||||||||||||||||
Tax benefit of above adjustments | (5,634 | ) | (0.29 | ) | (1,148 | ) | (0.06 | ) | (11,296 | ) | (0.60 | ) | (5,394 | ) | (0.29 | ) | ||||||||||||||||
Discrete tax items | (316 | ) | (0.02 | ) | (683 | ) | (0.04 | ) | 56,604 | 3.01 | (2,616 | ) | (0.14 | ) | ||||||||||||||||||
Impact of diluted shares 1 | -- | -- | -- | -- | -- | (0.10 | ) | -- | -- | |||||||||||||||||||||||
Non-GAAP basis | $ | 16,543 | $ | 0.86 | $ | 21,810 | $ | 1.17 | $ | 51,184 | $ | 2.63 | $ | 59,142 | $ | 3.17 |
1 |
For the nine months ended March 31, 2018, the weighted average diluted shares used to calculate EPS on a GAAP basis exclude potential common shares (stock options and restricted stock units) due to their antidilutive effect resulting from the Company’s reported net loss. For the nine months ended March 31, 2018, the weighted average diluted shares used to calculate EPS on a non-GAAP basis were approximately 19,473,000 shares. |
RECONCILIATION OF GAAP TO NON-GAAP OPERATING INCOME (LOSS) AND OPERATING MARGIN BY SEGMENT (in thousands, except percentages) |
||||||||||||||||||||||||||||||
Three Months Ended March 31, 2018 | ||||||||||||||||||||||||||||||
Security Division | Healthcare Division |
Optoelectronics and |
Corporate / |
Total | ||||||||||||||||||||||||||
% of Sales | % of Sales | % of Sales | % of Sales | |||||||||||||||||||||||||||
GAAP basis – operating income (loss) | $ | 21,028 | 12.4 | % | $ | (8,425 | ) | -19.3 | % | $ | 6,547 | 9.9 | % | $ | (11,407 | ) | $ | 7,743 | 2.9 | % | ||||||||||
Impairment, restructuring and other charges | 226 | 0.1 | % | 9,707 | 22.2 | % | 269 | 0.4 | % | 3,860 | 14,062 | 5.3 | % | |||||||||||||||||
Amortization of acquired intangible assets | 3,129 | 1.8 | % | - | - | 865 | 1.3 | % | - | 3,994 | 1.5 | % | ||||||||||||||||||
Non-GAAP basis– operating income (loss) | $ | 24,383 | 14.3 | % | $ | 1,282 | 2.9 | % | $ | 7,681 | 11.6 | % | $ | (7,547 | ) | $ | 25,799 | 9.7 | % | |||||||||||
Three Months Ended March 31, 2019 | ||||||||||||||||||||||||||||||
Security Division | Healthcare Division |
Optoelectronics and |
Corporate / |
Total | ||||||||||||||||||||||||||
% of Sales | % of Sales | % of Sales | % of Sales | |||||||||||||||||||||||||||
GAAP basis – operating income (loss) | $ | 24,943 | 12.9 | % | $ | 5,418 | 11.1 | % | $ | 7,320 | 10.3 | % | $ | (5,561 | ) | $ | 32,120 | 10.5 | % | |||||||||||
Impairment, restructuring and other charges | - | - | - | - | - | - | (1,777 | ) | (1,777 | ) | -0.6 | % | ||||||||||||||||||
Amortization of acquired intangible assets | 2,848 | 1.5 | % | - | - | 973 | 1.4 | % | - | 3,821 | 1.3 | % | ||||||||||||||||||
Non-GAAP basis– operating income (loss) | $ | 27,791 | 14.4 | % | $ | 5,418 | 11.1 | % | $ | 8,293 | 11.7 | % | $ | (7,338 | ) | $ | 34,164 | 11.2 | % | |||||||||||
Nine Months Ended March 31, 2018 | |||||||||||||||||||||||||||||
Security Division | Healthcare Division |
Optoelectronics and |
Corporate / |
Total | |||||||||||||||||||||||||
% of Sales | % of Sales | % of Sales | % of Sales | ||||||||||||||||||||||||||
GAAP basis – operating income (loss) | $ | 66,192 | 13.1 | % | $ | (6,975 | ) | -4.9 | % | $ | 16,224 | 8.6 | % | $ | (30,157 | ) | $ | 45,284 | 5.7 | % | |||||||||
Impairment, restructuring and other charges | 2,127 | 0.4 | % | 14,729 | 10.4 | % | 1,490 | 0.8 | % | 5,143 | 23,489 | 2.9 | % | ||||||||||||||||
Amortization of acquired intangible assets | 9,443 | 1.9 | % | 29 | 0.0 | % | 1,598 | 0.8 | % | - | 11,070 | 1.4 | % | ||||||||||||||||
Non-GAAP basis– operating income (loss) | $ | 77,762 | 15.4 | % | $ | 7,783 | 5.5 | % | $ | 19,312 | 10.2 | % | $ | (25,014 | ) | $ | 79,843 | 10.0 | % | ||||||||||
Nine Months Ended March 31, 2019 | |||||||||||||||||||||||||||||
Security Division | Healthcare Division |
Optoelectronics and |
Corporate / |
Total | |||||||||||||||||||||||||
% of Sales | % of Sales | % of Sales | % of Sales | ||||||||||||||||||||||||||
GAAP basis – operating income (loss) | $ | 74,056 | 13.4 | % | $ | 5,752 | 4.2 | % | $ | 22,212 | 10.4 | % | $ | (21,936 | ) | $ | 80,084 | 9.2 | % | ||||||||||
Impairment, restructuring and other charges | - | - | 3,526 | 2.5 | % | 420 | 0.2 | % | (2,792 | ) | 1,154 | 0.1 | % | ||||||||||||||||
Amortization of acquired intangible assets | 8,765 | 1.6 | % | - | - | 3,247 | 1.5 | % | - | 12,012 | 1.4 | % | |||||||||||||||||
Non-GAAP basis– operating income (loss) | $ | 82,821 | 15.0 | % | $ | 9,278 | 6.7 | % | $ | 25,879 | 12.1 | % | $ | (24,728 | ) | $ | 93,250 | 10.7 | % |
View source version on businesswire.com: https://www.businesswire.com/news/home/20190430006177/en/
Source:
For Additional Information, Contact:
OSI Systems, Inc.
Ajay Vashishat
Vice President, Business Development
Tel: (310) 349-2237
avashishat@osi-systems.com